These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 25420994)

  • 21. Emerging therapeutic options for asthma.
    Colice GL
    Am J Manag Care; 2011 Apr; 17 Suppl 3():S82-9. PubMed ID: 21761958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Bronchial thermoplasty: a real advancement in the treatment of asthma].
    Heinen V; Schleich F; Duysinx B; Kirsch M; Louis R
    Rev Med Suisse; 2014 Aug; 10(439):1544, 1546-8. PubMed ID: 25272671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of omalizumab on emergency-department visits, hospitalizations, and corticosteroid use among patients with uncontrolled asthma.
    Lafeuille MH; Dean J; Zhang J; Duh MS; Gorsh B; Lefebvre P
    Ann Allergy Asthma Immunol; 2012 Jul; 109(1):59-64. PubMed ID: 22727159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New treatments for severe treatment-resistant asthma: targeting the right patient.
    Chung KF
    Lancet Respir Med; 2013 Oct; 1(8):639-652. PubMed ID: 24461667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of combined treatment with corticosteroids and beta2 agonists in adults with asthma].
    ten Hacken NH; Kerstjens HA; Postma DS
    Ned Tijdschr Geneeskd; 2006 Apr; 150(16):892-7. PubMed ID: 16686088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of bronchial asthma using a new adjustable combination treatment plan: Asthma Control Plan (ATACO)].
    Kardos P; Brüggenjürgen B; Martin A; Meyer-Sabellek W; Richter K; Vogelmeier C; Willlich SN; Buhl R
    Pneumologie; 2001 May; 55(5):253-7. PubMed ID: 11449612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Corticosteroid treatment in airways narrowing].
    Chazan R
    Pneumonol Alergol Pol; 2008; 76(2):96-100. PubMed ID: 18464224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The add-on effect of omalizumab on patients with uncontrolled bronchial asthma].
    Minami Y; Endo S; Okumur S; Sasaki T; Yamamoto Y; Ogasa T; Osanai S; Ohsaki Y
    Nihon Kokyuki Gakkai Zasshi; 2011 Nov; 49(11):793-9. PubMed ID: 22171481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of monoclonal antibodies in the treatment of severe asthma.
    Tourangeau LM; Kavanaugh A; Wasserman SI
    Ther Adv Respir Dis; 2011 Jun; 5(3):183-94. PubMed ID: 21393345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulatory and biologic therapies for severe refractory asthma.
    Polosa R; Morjaria J
    Respir Med; 2008 Nov; 102(11):1499-510. PubMed ID: 19012848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel therapies in asthma: leukotriene antagonists, biologic agents, and beyond.
    Papierniak ES; Lowenthal DT; Harman E
    Am J Ther; 2013 Jan; 20(1):79-103. PubMed ID: 23299231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update on biologic-based therapy in asthma.
    Walsh GM
    Immunotherapy; 2013 Nov; 5(11):1255-64. PubMed ID: 24188679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is mild asthma really 'mild'?
    Fabbri LM; Stoloff S
    Int J Clin Pract; 2005 Jun; 59(6):692-703. PubMed ID: 15924598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
    Aubier M; Haughney J; Selroos O; van Schayck OC; Ekström T; Ostinelli J; Buhl R
    Ther Adv Respir Dis; 2011 Oct; 5(5):289-98. PubMed ID: 21586508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical benefits of 7 years of treatment with omalizumab in severe uncontrolled asthmatics.
    Pace E; Ferraro M; Bruno A; Chiappara G; Bousquet J; Gjomarkaj M
    J Asthma; 2011 May; 48(4):387-92. PubMed ID: 21391878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bronchial thermoplasty: a novel technique in the treatment of severe asthma.
    Castro M; Musani AI; Mayse ML; Shargill NS
    Ther Adv Respir Dis; 2010 Apr; 4(2):101-16. PubMed ID: 20435668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
    Holgate ST; Chuchalin AG; Hébert J; Lötvall J; Persson GB; Chung KF; Bousquet J; Kerstjens HA; Fox H; Thirlwell J; Cioppa GD;
    Clin Exp Allergy; 2004 Apr; 34(4):632-8. PubMed ID: 15080818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New drugs for asthma.
    Barnes PJ
    Semin Respir Crit Care Med; 2012 Dec; 33(6):685-94. PubMed ID: 23047317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [How can asthma in children be controlled?].
    Rousso S; Shoseyov D; Kerem E
    Harefuah; 2013 May; 152(5):299-303, 307. PubMed ID: 23885456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.